Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 5;69(Suppl 2):S58-S65.
doi: 10.1093/cid/ciz456.

Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010-2016

Evans M Mpabalwani  1   2 , Chileshe Lukwesa-Musyani  3 , Akakambama Imamba  2 , Ruth Nakazwe  3 , Belem Matapo  4 , Chilweza M Muzongwe  5 , Trust Mufune  5 , Elizabeth Soda  6 , Jason M Mwenda  7 , Chelsea S Lutz  8   9 , Tracy Pondo  6 , Fernanda C Lessa  6
Affiliations

Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010-2016

Evans M Mpabalwani et al. Clin Infect Dis. .

Abstract

Background: Pneumococcus is a leading cause of pneumonia and meningitis. Zambia introduced a 10-valent pneumococcal conjugate vaccine (PCV10) in July 2013 using a 3-dose primary series at ages 6, 10, and 14 weeks with no booster. We evaluated the impact of PCV10 on meningitis and pneumonia hospitalizations.

Methods: Using hospitalization data from first-level care hospitals, available at the Ministry of Health, and from the largest pediatric referral hospital in Lusaka, we identified children aged <5 years who were hospitalized with pneumonia or meningitis from January 2010-December 2016. We used time-series analyses to measure the effect of PCV10 on monthly case counts by outcome and age group (<1 year, 1-4 years), accounting for seasonality. We defined the pre- and post-PCV10 periods as January 2010-June 2013 and July 2014-December 2016, respectively.

Results: At first-level care hospitals, pneumonia and meningitis hospitalizations among children aged <5 years accounted for 108 884 and 1742 admissions in the 42 months pre-PCV10, respectively, and 44 715 and 646 admissions in the 30 months post-PCV10, respectively. Pneumonia hospitalizations declined by 37.8% (95% confidence interval [CI] 21.4-50.3%) and 28.8% (95% CI 17.7-38.7%) among children aged <1 year and 1-4 years, respectively, while meningitis hospitalizations declined by 72.1% (95% CI 63.2-79.0%) and 61.6% (95% CI 50.4-70.8%), respectively, in these age groups. In contrast, at the referral hospital, pneumonia hospitalizations remained stable and a smaller but significant decline in meningitis was observed among children aged 1-4 years (39.3%, 95% CI 16.2-57.5%).

Conclusions: PCV10 introduction was associated with declines in meningitis and pneumonia hospitalizations in Zambia, especially in first-level care hospitals.

Keywords: Zambia; meningitis; pneumococcal conjugate vaccine; pneumococcus; pneumonia.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Modeled and observed pneumonia hospitalization counts by age and month/year of discharge using MOH and UTH data, Zambia, 2010–2016. Abbreviations: MOH, Ministry of Health; PCV10, 10-valent pneumococcal conjugate vaccine; UTH, University Teaching Hospital.
Figure 2.
Figure 2.
Estimated reductions in in-hospital pneumonia and meningitis deaths among hospitalized children aged <5 years post-PCV10 using MOH and UTH data, Zambia, 2010–2016. A, Pneumonia hospitalization deaths. B, Meningitis hospitalization deaths. Abbreviations: MOH, Ministry of Health; PCV10, 10-valent pneumococcal conjugate vaccine; UTH, University Teaching Hospital.
Figure 3.
Figure 3.
Modeled and observed meningitis hospitalization counts by age and month/year of discharge using MOH and UTH data, Zambia, 2010–2016. Impact on pneumonia hospitalizations post-PCV10: (A) −72.1% (95% CI −79.0 to −63.2%); (B) −61.6% (95% CI −70.8 to −50.4%); (C) −11.5% (95% CI −24.0 to 37.3%); and (D) −39.3% (95% CI −57.5 to −16.2%). Abbreviations: CI, confidence interval; MOH, Ministry of Health; PCV10, 10-valent pneumococcal conjugate vaccine; UTH, University Teaching Hospital.
See this image and copyright information in PMC

References

    1. American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red book: 2006 report of the Committee on Infectious Diseases. 27th ed Elk Grove Village, Illinois: American Academy of Pediatrics, 2006:525–537.
    1. World Health Organization. Estimated Hib and pneumococcal deaths for children under 5 years of age, 2008. Available at: http://www.who.int/immunization/monitoring_surveillance/burden/estimates.... Accessed 19 November 2018.
    1. Walker CLF, Rudan I, Liu L, et al. . Global burden of childhood pneumonia and diarrhoea. Lancet 2013; 381:1405–16. - PMC - PubMed
    1. GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis 2018; 18:1191–1210. doi: 10.1016/S1473-3099(18)30310-4 - DOI - PMC - PubMed
    1. van Aalst M, Lötsch F, Spijker R, et al. . Incidence of invasive pneumococcal disease in immunocompromised patients: a systematic review and meta-analysis. Travel Med Infect Dis 2018; 24:89–100. - PubMed

Publication types

MeSH terms

Substances